August 6th 2025
The vasopressin V1b antagonist reduced depressive symptoms, with greater effects in genetically-selected patients using a precision psychiatry approach.
July 31st 2025
Your daily dose of the clinical news you may have missed.
June 4th 2025
May 20th 2025
ACOG 2025: Elizabeth Mollard, PhD, discusses her research on how Medicaid policies influence postpartum depression screening rates.
April 21st 2025